RALEIGH, N.C. – June 30, 2026 – With days left to act in the legislative session, cancer advocates urgently call on North Carolina lawmakers to pass legislation improving access to biomarker testing.
Today, legislation aiming to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans, was voted out of committee and will soon be heard by the full House. This marks the final step before the bill goes to Governor Matt Meyer who, earlier this year, identified biomarker testing access as a priority.
SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.
DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain the most important criteria used for determining when testing is to be covered, drawing praise from cancer survivors and patient advocates.
Cancer Advocates Applaud the State Legislature's Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.
Late Friday, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) released a final rule on the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters (NBPP) for plan year 2027.
Visual Elements Available for Download:
Cancer Advocates Gathered at the Statehouse Today to Say Ohio Can and Must Do Better to Reduce the Burden of Cancer
NASHVILLE, Tenn. – Gov.